For instance, the prognostic significance of HER2 and MET protein expression level, FGFR2 gene amplification, and downstream mediators pS6 and pERK was evaluated for their potential utility as biomarkers in patients with gastric adenocarcinoma [113]. The gene discussed is MET; the disease is gastric adenocarcinoma.